SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001818382-22-000028
Filing Date
2022-04-29
Accepted
2022-04-29 06:41:36
Documents
5
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A huma-2022def14a.htm DEF 14A 575995
2 ceosignaturea.jpg GRAPHIC 51912
3 humaproxycardpg1a.jpg GRAPHIC 79576
4 humaproxycardpg2a.jpg GRAPHIC 73466
5 image_0a.jpg GRAPHIC 3629
  Complete submission text file 0001818382-22-000028.txt   853743
Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Filer) CIK: 0001818382 (see all company filings)

IRS No.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39532 | Film No.: 22869969
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences